Delivering Specialized Analytical Talent in a Competitive Biotech Hub
How we helped CRISPR Therapeutics secure a Senior Scientist II in one of the most competitive life sciences markets in the US.
2
Critical commercial appointments
3.5
Days to present the hired candidates
80
% of candidates interviewed
CRISPR Therapeutics partnered with us to fill a critical Senior Scientist II role within their Late-Stage Analytical and CMC team in Boston, MA. Operating in one of the country’s most competitive biotech markets, CRISPR needed a candidate with rare technical expertise and the right cultural fit. Despite challenges around talent scarcity, high competition, and candidate dropouts, we successfully delivered the hire.
Challenges Identified
CRISPR required a Senior Scientist II with advanced expertise in late-stage analytical assay development and validation for biologics.
Boston’s biotech market posed unique challenges—strong competition from neighboring firms, limited available talent, and aggressive counteroffers. Despite internal recruitment efforts, CRISPR struggled to find qualified candidates with the required analytical depth, flow cytometry experience, and familiarity with CDMO and CTL partnerships.
They needed a search partner with deep sector insight, a targeted strategy, and the ability to maintain candidate engagement in a fast-moving market.
What Was at Stake
Leaving this key scientific position unfilled risked delays in product release and validation, potentially disrupting late-stage development programs and impacting collaboration with CDMOs and testing laboratories. This could have caused setbacks in meeting business and regulatory milestones.
Our Strategy and Approach
Results
By securing this critical hire, CRISPR Therapeutics avoided costly project delays and maintained momentum in its late-stage development work. The partnership reinforced their ability to deliver against key scientific and regulatory milestones—without disruption.
Impact
By securing this key hire, CRISPR Therapeutics maintained momentum in their late-stage product release and validation efforts. Our partnership allowed them to continue development work without disruption, ensuring that their project timelines remained intact and supporting their strategic objectives in advancing their products.
Build Your Own Success Story
Let us help you find the specialized talent your projects depend on—just as we did for CRISPR Therapeutics. Get in touch to discuss your hiring needs and start building your success story today.
Explore Similar Projects
With a product launch imminent, fast-growing Swedish medical device firm, Acarix, approached us to place two commercial leads within the DACH and US regions.
Reaction Biology were looking to recruit two Business Development Directors in France and Germany, but were struggling to appoint the right talent.
With fast-tracked designation for their lead product, AveXis required highly-skilled candidates with expertise in neuroscience and orphan diseases to lead their product to commercialization.